The Global Breast Care Initiative strives to combine knowledge compassion, resources and technology to better the lives of girls and women around the world.


“A Clinical study by Broach et al reported iBreastExam sensitivity of 86% and specificity of 89% to detect breast masses as compared to standard of care imaging tests such as mammography and breast ultrasound. A Study by Somashekhar et al reported sensitivity of 85% and specificity of 93% to detect breast lesions in a double-blind study. ” — Rohan Khandelwal, MD , Breast Onco-surgeon, W Pratiksha Hospital, India

We are fortunate in our most recent partnership with UESciences and the iBreastExam hand-held digital breast exam device. This partnership allows GBCI to utilize the very latest in breast health technology, portability, safety, and low cost to allow women of all ages and resources access to breast health services.

iBreastExam has reported comparable performance characteristics to the standard of care

imaging vs. screening mammography.

Rohan Khandelwal, MD , Breast Onco-surgeon, W Pratiksha Hospital, India

ultra-portable & radiation-free


FDA & CE Approved,radiation free, an iBE handheld unit is an option for all women including those with dense breast tissue. This new technology strives to overcome several of the fundamental barriers seen with current mammography screening including cost, psychosocial, logistical and cultural issues.